AlloVir, Inc. (ALVR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...
Apple Vision Pro, a headset-type spatial computing device, is equipped with the M2 chip and R1 chip, and allows you to experience high-quality VR (virtual space) and AR (augmented reality) by ...
As of April 24, 2023, the average one-year price target for AlloVir is 22.44. The forecasts range from a low of 16.16 to a high of $31.50. The average price target represents an increase of 544.83% ...
Did you know you can technically play SteamVR games like Half-Life: Alyx (2020) on Vision Pro? Well, now you do, as the leading app dedicated to bringing SteamVR connectivity to a ton of standalone ...
Want to enjoy a SteamVR game inside your Oculus Go? Our guide to using ALVR can help. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Oculus Go, ...
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, both ...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares ...
AlloVir, Inc. ALVR announced that the FDA has granted Regenerative Medicine Advanced Therapy (“RMAT”) designation to its allogeneic, off-the-shelf, multi-virus-specific T-cell therapy, posoleucel, for ...
Gilead has purchased $10.9 million in shares of AlloVir, a biotech company specializing in cell therapy and organ transplant, giving it a 15% ownership of the company. AlloVir's lead product, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results